Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumors.
about
An integrated analysis of miRNA and gene copy numbers in xenografts of Ewing's sarcomaTwenty Years on: What Do We Really Know about Ewing Sarcoma and What Is the Path Forward?The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation.Ewing tumor: tumor biology and clinical applications.Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities.The clinical use of biomarkers as prognostic factors in Ewing sarcoma.Genes proximal and distal to MYCN are highly expressed in human neuroblastoma as visualized by comparative expressed sequence hybridizationPrognostic impact of chromosomal aberrations in Ewing tumoursBiomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children's Oncology Group.Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors.Molecular abnormalities in Ewing's sarcoma.Adult primary pulmonary primitive neuroectodermal tumor: molecular features and translational opportunities.Response of Ewing tumor cells to forced and activated p53 expression.Inconspicuous insertion 22;12 in myxoid/round cell liposarcoma accompanied by the secondary structural abnormality der(16)t(1;16).Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss.Loss of 13q14-q21 and gain of 5p14-pter in the progression of leiomyosarcoma.Ewing's sarcoma metastasis to the gastric wall in a 72-year-old patient.
P2860
Q21198840-D1A6A514-B7C6-400A-A9D4-4FAA82AE7F50Q26782649-7987A5DB-1FB7-42B6-9AC4-66B45D5C16C9Q33881163-1A6ACF6C-2102-4CA0-B47E-A6CC8C84747FQ34317033-11A9E8F6-B5DA-48A2-8D03-76AEFE4394B8Q35057457-35DFA6B0-6DAE-48BB-ACC2-75299C9C7854Q35957979-D10278F5-11BC-4B8C-8A25-C4A0D2C339BCQ36357428-BF48A1EE-DD64-40F8-8822-5D8533187D0AQ36644524-5151B66B-6393-4C60-9323-BD73A7F3B034Q36907188-D3CDC84D-6D12-47A7-B908-3CDD0371439CQ37078506-24D8A3BD-A7DD-4374-BCD1-A66C1BCBF366Q37300040-FFE649B3-8681-4C4F-8D98-0F74A44E4FACQ38056841-AE6D8610-FB8C-41A6-922D-2BDB2D2F5A56Q40645830-259258AE-2783-41EC-A400-252A57CB7D35Q41776942-1B423795-197F-4978-88D0-AAD125517A80Q44550448-A5F932E6-452F-41B0-99DC-D94D4A71DC20Q53376961-58623809-2160-47EF-A3B2-EB91442C1750Q53561818-BBFD000E-A661-4FA3-827C-35245C301081
P2860
Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumors.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumors.
@en
Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumors.
@nl
type
label
Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumors.
@en
Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumors.
@nl
prefLabel
Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumors.
@en
Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumors.
@nl
P2093
P2860
P50
P1476
Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumors.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1098-2264(199903)24:3<243::AID-GCC10>3.0.CO;2-A
P577
1999-03-01T00:00:00Z